Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medeval Group

1983 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of drug research intended to the early development of new medicines. The company's specific expertise is in clinical pharmacology, pharmacokinetics and bioanalysis, enabling the world's leading pharmaceutical and biotechnology companies, to trial a range of experimental drugs.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Skelton House, Manchester Science Park
  • Lloyd Street North
  • Manchester M15 6SH
  • England

Medeval Group Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medeval Group‘s full profile, request access.

Request full access to PitchBook

Medeval Group Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Medeval Group‘s full profile, request access.

Request full access to PitchBook

Medeval Group Executive Team (1)

Name Title Board
Seat
Contact
Info
Steve Toon Vice President